Researchers Develop Vaccine Candidates to Prevent Epstein-Barr Virus
An NIH research team has determined how several antibodies induced by Epstein-Barr virus (EBV) block infection of cells grown in the laboratory.
Stopping Alzheimer’s with a Preventative Vaccine?
Despite the many vaccine candidates undergoing clinical trials, experts doubt an effective vaccine for Alzheimer’s disease is on the horizon.
Sanofi Receives Narrow FDA Approval for Dengue Vaccine
FDA has given Sanofi SA’s dengue vaccine Dengvaxia a narrow approval since the vaccine can cause severe infections in some people.
Campaign Launched to Remind Families Teens Need Second Meningitis Booster Shot
The National Meningitis Association has launched a campaign to encourage more teens to get the meningitis booster.
Connecting with People Who Have Suffered from Diseases Can Change Attitudes Toward Vaccines
A BYU study found introducing vaccine-hesitant people to people affected by vaccine-preventable diseases can decrease vaccine hesitancy.
Genetics Linked to Immunity to Childhood Vaccines
Researchers at the University of Oxford in the United Kingdom have linked several genetic variations with the level of protective antibodies generated following routine childhood immunizations.
FDA Approves Pediatric Hexavalent Combination Vaccine
Sanofi and Merck’s Vaxelis has been approved by the U.S. Food and Drug Administration.
Flu Pamphlet Impacts Parents’ Decision to Vaccinate Kids
A new study by researchers at Columbia University has found handing a pamphlet about influenza (flu) to parents in pediatricians’ waiting rooms can have a significant impact on increasing the uptake of the flu vaccine.
Following the Disease: Trends and Outbreaks Drive Subtle Changes to Vaccine Recommendations for Adolescents and Young Adults
Recent disease trends among adolescents and young adults have fueled vaccine schedule updates. Many have been outbreak-driven; others reflect vaccine improvements and innovations. All are critical to improve the health.
Accelerated Dosing Regimen Approved for Japanese Encephalitis Vaccine
Valneva USA has received FDA approval of an accelerated dosing regimen for IXIARO (Japanese encephalitis vaccine, inactivated, adsorbed).
